PIONIR Study (Presillion™ and Presillion™ Plus Stent Systems)

PHASE4CompletedINTERVENTIONAL
Enrollment

278

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

June 30, 2011

Conditions
Ischemic Heart Disease
Interventions
DEVICE

Catheterization, stent deployment

Standard catheterization procedure including Bare Metal Stent deployment.

Trial Locations (16)

1090

UZ Brussel, Brussels

2020

ZNA Middelheim, Antwerp

4000

CHU de Liege, Liège

6000

CHU Charleroi, Charleroi

12203

Charité - Campus Benjamin Franklin, Berlin

18101

EMEK Medical Center, Afula

42150

Sanz Medical Center, Laniado Hospital, Netanya

53721

Helios Klinkum, Siegburg

60389

CardioVascular Center Frankfurt Sankt Katharinen, Frankfurt

69120

University Hospital of Heidelberg, Heidelberg

70300

Assaf Harofeh Medical Center, Ẕerifin

91120

Hadassah Medical Organization, Jerusalem

D-23795

Herz-Kreislauf-Zentrum Segeberger Kliniken, Bad Segeberg

D 78050

Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH, Villingen-Schwenningen

Unknown

Sahlgrenska University Hospital, Gothenburg

Lund University Hospital, Lund

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medinol Ltd.

INDUSTRY

NCT00840775 - PIONIR Study (Presillion™ and Presillion™ Plus Stent Systems) | Biotech Hunter | Biotech Hunter